A Follow-up Study to Assess Resistance to ABT-072 in HCV-infected Subjects Administered ABT-072 in Prior ABT-072 Studies

Completed · Phase 2

Conditions studied: Hepatitis C Virus Infection

In brief

This is a follow-up study with no treatment and only samples being collected.

Key facts

Study ID

NCT00872196

Run by

AbbVie (prior sponsor, Abbott)

People needed

5

Starts

2009-04-01

Expected to finish

2010-04-01

Last updated by the study team

2013-04-01

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Main Selection Criteria: A subject that has received either ABT-072 or placebo in a prior study involving ABT-072.

You may not qualify if…

• The investigator considers the subject unsuitable for the study for any reasons inclusive of, but not limited to, failure to comply with study procedures in a prior ABT-072 clinical study.

Where it is running

• Site Reference ID/Investigator# 18222 — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.